On September 1, 2015, the board of directors of Neos Therapeutics, Inc. appointed Ms. Beth Hecht to serve as a director of the company, effective September 1, 2015. Ms. Hecht will serve as a Class III director, to serve until the company's annual meeting of stockholders next following December 31, 2017, or until her successor is duly
elected and qualified, and was also elected to serve on the company's Nominating and Corporate Governance Committee.